sameAs
A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or BThe Second Multicenter Hemophilia Cohort StudyThe Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and BPharmacokinetic (PK)Research on Chinese Children of HemophiliaATHN 7: Hemophilia Natural History StudyPersonalized Medicine for Canadians With HemophiliaLow-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in ChinaBleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet TherapiesAn Expanded Access Program of Emicizumab in Participants With Hemophilia A With InhibitorsClinical Trial of Factor XIII (FXIII) ConcentrateImpact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle ArthropathyHaemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsPost Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia BRecombinant Factor VIIa (NovoSeven) on Restoring Coagulation ActivationStudy Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia BSafety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.Socialization of Adult Men With Congenital Hemophilia A or BBAX 326 Surgery Study in Hemophilia B PatientsThrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With InhibitorsEpidemiological Study on Haemophilia Care and Orthopaedic Status in Developing CountriesOsteoporosis and MRI Study in HemophiliaStudy to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ALong-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia AExpanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodiesStudy Evaluating On-Demand Treatment Of Xyntha In Chinese SubjectsStudy Evaluating On-Demand Treatment With BeneFIX In Chinese SubjectsInternational PMS Study - KOGENATE BayerA Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in FranceA Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionA Study of Haemophilia B Patients Who Have Undergone Gene TherapyTrial of NovoSeven® in Haemophilia - Joint BleedsEfficacy of NovoSeven® in Bleeding Prophylaxis in HemophiliaPET Imaging of Hemophilic ArthropathyA Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe HemophiliaGait Examination in Patients With Hemophilia in AustriaWeb Accessible Population Pharmacokinetics Service - Hemophilia: Sources of VariabilityVirtual Reality for HemophiliaHEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of UltrasoundSafety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy VolunteersPharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State
P1050
P1915
Consensus recommendations for the diagnosis and treatment of acquired hemophilia ARituximab for eradicating inhibitors in people with acquired haemophilia ABypassing agent prophylaxis in people with hemophilia A or B with inhibitorsRecombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitorsDesmopressin acetate (DDAVP) for preventing and treating bleeding in people with mild or moderate haemophilia AInterventions for treating acute bleeding episodes in people with acquired hemophilia AImmune tolerance induction for treating inhibitors in people with congenital haemophilia A or BImmune tolerance induction for treating inhibitors in people with congenital haemophilia A or BClotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitorsClotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BClotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitorsRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitorsGene conversion and evolution of Xq28 duplicons involved in recurring inversions causing severe hemophilia AComparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia ASpinal subdural hematoma revealing hemophilia A in a child: A case reportGenetic analysis of haemophilia A in BulgariaRituximab for eradicating inhibitors in people with acquired haemophilia AHuman von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia APotential role of a new PEGylated recombinant factor VIII for hemophilia A.The story of a unique molecule in hemophilia A: recombinant single-chain factor VIIIThe anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia AHeavy hematuria requiring cystectomy in a patient with hemophilia A: a case report and literature reviewF8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysisThree-dimensional gait analysis can shed new light on walking in patients with haemophiliaHemophilia A: an ideal disease to correct in uteroAcquired hemophilia A: an underdiagnosed, severe bleeding disorderAlloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicitySwitching treatments in haemophilia: is there a risk of inhibitor development?Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophiliasImportance of immune response genes in hemophilia AProgress and challenges in the development of a cell-based therapy for hemophilia ARecombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A micePorcine model of hemophilia AGenome-editing technologies for gene correction of hemophiliaPreimplantation genetic diagnosis of hemophilia ATherapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia AHemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectorsComparison of bypassing agents in bleeding reduction in treatment of bleeding episodes in patients with haemophilia and inhibitors
P921
description
Krankheit
@de
X-linked disease that has mate ...... oagulation much more prolonged
@en
forma più comune di emofilia, caratterizzata da emorragie spontanee o prolungate
@it
maladie
@fr
trastorno genético asociado con hemorragia grave
@es
Наиболее частая форма гемофилии, вызванная дефицитом фактора свёртывания крови VIII.
@ru
name
A형혈우병
@ko
Factor VIII
@ca
Hemofiliya A
@az
emofilia A
@it
hemofilia A
@es
hemofilia A
@pt
hemofilio A
@eo
hemophilia A
@en
hémophilie A
@fr
Гемофилия A
@ru
type
label
A형혈우병
@ko
Factor VIII
@ca
Hemofiliya A
@az
emofilia A
@it
hemofilia A
@es
hemofilia A
@pt
hemofilio A
@eo
hemophilia A
@en
hémophilie A
@fr
Гемофилия A
@ru
altLabel
Congenital factor VIII disorder
@en
Hemophilia A (disorder)
@en
Hemophilia A
@en
Subhemophilia
@en
factor VIII deficiency
@en
haemophilia A
@en
hémophilie classique
@fr
甲型血友病
@zh
第VIII因子欠乏症
@ja
第VIII因子欠損症
@ja
prefLabel
A형혈우병
@ko
Factor VIII
@ca
Hemofiliya A
@az
emofilia A
@it
hemofilia A
@es
hemofilia A
@pt
hemofilio A
@eo
hemophilia A
@en
hémophilie A
@fr
Гемофилия A
@ru
P279
P2888
P2892
P672
P2581
P486
P6366
P646
P1199
P1417
science/hemophilia-A
P1461
haemophilia-a-factor-viii-deficiency